Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Biomerieux 69 Marcy L'Etoile (OTC: BMXMF).

Full DD Report for BMXMF

You must become a subscriber to view this report.


Recent News from (OTC: BMXMF)

Biomerieux SA (BMXMF) CEO Alexandre Mérieux on Q2 2018 Results Conference Call - Earnings Call Transcript
Biomerieux SA (BMXMF) Q2 2018 Results Conference Call September 05, 2018 08:30 AM Executives Sylvain Morgeau - Investor Relations Alexandre Mérieux - Chief Executive Officer Guillaume Bouhours - Chief Financial Officer Analysts RomainZana - Exane Bill Quirk - Piper J...
Source: SeekingAlpha
Date: September, 06 2018 18:13
T2 Biosystems Might Hit A Home Run In 2018
T2 Biosystems ( TTOO ) is a small in vitro diagnostics company that has developed a technology platform that offers a rapid, sensitive and simple alternative to existing diagnostic methodologies. The company's T2 Magnetic Resonance technology (T2MR) aims to lower mortality rates, improve...
Source: SeekingAlpha
Date: February, 26 2018 19:36

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-12-1069.9669.9669.9669.9670
2018-12-0769.2070.4470.4469.20710
2018-12-0669.2569.2569.2569.25110
2018-12-05N/A71.91N/AN/A0
2018-12-04N/A71.91N/AN/A0

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-0770071098.5915Short
2018-12-06110110100.0000Short
2018-12-03103103100.0000Short
2018-11-3012010.4975Cover
2018-11-2666100.0000Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on BMXMF.


About Biomerieux 69 Marcy L'Etoile (OTC: BMXMF)

Logo for Biomerieux 69 Marcy L'Etoile (OTC: BMXMF)

Biomerieux SA designs, develops, manufactures, and markets in vitro diagnostic systems for clinical and industrial applications. The company s diagnostic systems consist of reagents and consumables used to conduct biological tests, for use in performing screening, diagnostic assistance, prognosis, and treatment monitoring instruments, platforms, or autoanalyzers used for automated testing at high or low throughputs software to process analyses and systems to interpret the biological test results and related services, such as the installation and maintenance of instruments, user training, or the audit of laboratory workflows. It offers diagnostic systems for clinical applications, including the diagnosis of infectious diseases, comprising HIV, tuberculosis, and respiratory diseases, as well as cardiovascular diseases and targeted cancers based on the analysis of biological samples, such as blood, saliva, and urine and for industrial applications, including the analysis of microbiological manufacturing, such as food, pharmaceuticals, and cosmetics. The company markets and sells its products through a network of distributors to private sector analysis laboratories, hospital laboratories, blood banks, and physician office laboratories food, pharmaceutical, and cosmetics industries and independent quality control laboratories. It has operations in Europe, the Middle East, Africa, North America, Asia Pacific, and Latin America. The company was founded in and is headquartered in Marcy l Etoile, France.

 

 

 

Current Share Structure

     



    Daily Technical Chart for (OTC: BMXMF)

    Daily Technical Chart for (OTC: BMXMF)


    Stay tuned for daily updates and more on (OTC: BMXMF)

    It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

    More to come on (OTC: BMXMF)

    Do your DD and if you choose, be ready to go!


     

    The Research: All source information contained in this email is from the public sources mentioned below.

     

     
     

    Thank you

    DD Report
    @DDReports

     

     


    Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in BMXMF is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of BMXMF and does not buy, sell, or trade any shares of BMXMF. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/